<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Am J Dermatopathol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Am J Dermatopathol</journal-id>
      <journal-id journal-id-type="publisher-id">ajd</journal-id>
      <journal-title-group>
        <journal-title>The American Journal of Dermatopathology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0193-1091</issn>
      <issn pub-type="epub">1533-0311</issn>
      <publisher>
        <publisher-name>The American Journal of Dermatopathology</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26588343</article-id>
      <article-id pub-id-type="pmc">4894811</article-id>
      <article-id pub-id-type="publisher-id">AJD-D-14-00364</article-id>
      <article-id pub-id-type="doi">10.1097/DAD.0000000000000311</article-id>
      <article-id pub-id-type="art-access-id">00019</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Extraordinary Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Spontaneous Involution of Congenital Melanocytic Nevus With Halo Phenomenon</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Noo Ri</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chung</surname>
            <given-names>Hee-Chul</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hong</surname>
            <given-names>Hannah</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Jin Wook</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Ahn</surname>
            <given-names>Sung Ku</given-names>
          </name>
          <degrees>MD, PhD</degrees>
        </contrib>
        <aff>Department of Dermatology, Institute of Lifestyle Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.</aff>
      </contrib-group>
      <author-notes>
        <corresp>Reprints: Sung Ku Ahn, MD, PhD, Department of Dermatology, Institute of Lifestyle Medicine, Yonsei University Wonju College of Medicine, 162 Ilsan-dong, Wonju 220-701, Republic of Korea (e-mail: <email>ahnsk@yonsei.ac.kr</email>).</corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>11</month>
        <year>2015</year>
      </pub-date>
      <volume>37</volume>
      <issue>12</issue>
      <fpage>e137</fpage>
      <lpage>e139</lpage>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2015 Wolters Kluwer Health, Inc. All rights reserved.</copyright-statement>
        <copyright-year>2015</copyright-year>
      </permissions>
      <self-uri xlink:type="simple" xlink:href="ajd-37-e137.pdf"/>
      <abstract>
        <title>Abstract:</title>
        <p>Congenital melanocytic nevus (CMN) is a neural crest-derived hamartoma, which appear at or soon after birth. CMN has a dynamic course and may show variable changes over time, including spontaneous involution. Spontaneous involution of CMN is a rare phenomenon and is often reported in association with halo phenomenon or vitiligo. The mechanism of halo phenomenon is yet to be investigated but is suggested to be a destruction of melanocytes by immune responses of cytotoxic T cells or IgM autoantibodies. Here, the authors report an interesting case of spontaneously regressed medium-sized CMN with halo phenomenon and without vitiligo, which provides evidence that cytotoxic T cells account for the halo formation and pigmentary regression of CMN.</p>
      </abstract>
      <kwd-group>
        <title>Key Words:</title>
        <kwd>congenital melanocytic nevus</kwd>
        <kwd>cellular immunity</kwd>
        <kwd>halo phenomenon</kwd>
        <kwd>involution</kwd>
        <kwd>vitiligo</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>STATUS</meta-name>
          <meta-value>ONLINE-ONLY</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s1">
      <title>INTRODUCTION</title>
      <p>Congenital melanocytic nevus (CMN) is considered to be a neural crest-derived hamartoma, which appears at or soon after birth,<xref rid="R1" ref-type="bibr">1</xref> with incidence of 0.2&#x2013;2.1 in neonates.<xref rid="R2" ref-type="bibr">2</xref> CMN has a dynamic course and may change over time. It can increase in size, become darker in color, become hairy, or even lose its pigmentation.<xref rid="R3" ref-type="bibr">3</xref> Spontaneous involution of CMN is a rare phenomenon, and it is often reported in association with halo phenomenon or vitiligo.<xref rid="R4" ref-type="bibr">4</xref>&#x2013;<xref rid="R7" ref-type="bibr">7</xref></p>
      <p>The halo nevus or leukoderma acquisitum centrifugum, also called as Sutton nevus, is usually observed around congenital or acquired melanocytic nevi.<xref rid="R4" ref-type="bibr">4</xref> Halo phenomenon may also develop around Mongolian spot, caf&#xE9; au lait macules, neurofibroma, basal cell carcinoma, seborrheic keratosis, histiocytoma, and flat warts.<xref rid="R8" ref-type="bibr">8</xref> The clinical manifestation of halo phenomenon is characterized by progressive lightening of the color, disappearance of central nevus afterwards, and persistence of hypopigmentation.<xref rid="R5" ref-type="bibr">5</xref></p>
      <p>To date, the mechanism of halo phenomenon is suggested to be a destruction of melanocytes by immune responses of cytotoxic T cells or IgM autoantibodies. Musette et al<xref rid="R9" ref-type="bibr">9</xref> reported local proliferation of T-cell clones activated by common nevus antigens found in different halo nevi of the same patient. However, few reports about concomitant onset of vitiligo and halo nevus suggest that immunological factors may play a crucial role.<xref rid="R10" ref-type="bibr">10</xref></p>
      <p>Here, we report a case of medium-sized CMN with halo phenomenon and pigmentary regression without vitiligo development in a young girl. Its histopathologic findings provide evidence that cytotoxic T cells account for the halo formation and pigmentary regression of CMN.</p>
    </sec>
    <sec id="s2">
      <title>CASE REPORT</title>
      <p>A 13-year-old girl visited our department for evaluation of a melanocytic nevus, which appeared since birth and showed progressive depigmentation for 5 years. On physical examination, a white to grayish, 10 &#xD7; 7 cm sized, irregularly bordered patch with brown to tan colored macules inside the patch was observed (Fig. <xref ref-type="fig" rid="F1">1</xref>). There was no erythema in the lesion, and the patient did not complain of any subjective symptom. The child did not have any medical history and a familial history of CMN. No other depigmented lesion was noticed by full skin examination. Histopathologic examination from the center of depigmented patch showed nests and cords of nevus cells that do not contain melanin pigment in the mid-to-deep dermis, confirming the diagnosis of CMN (Fig. <xref ref-type="fig" rid="F2">2</xref>A). Dense infiltration of mononuclear cells around the nevus cells in superficial dermis and periadnexal structures was also seen (Fig. <xref ref-type="fig" rid="F2">2</xref>B). No nevus cell showed a sign of cellular atypia. Immunohistochemistry showed positive staining for S100 and MART-1 but negative for HMB-45 in nevus cells. Cells labeled with Ki-67 revealed to be less than 2% of total nevus cells. The immunophenotype analysis of the mononuclear infiltrate revealed that the cells were composed predominantly of CD5-positive T cells, and CD4:CD8 ratio was approximately 1:6. Only few cells were CD20 positive (Fig. <xref ref-type="fig" rid="F3">3</xref>). Although the lesion showed no risk for malignancy, the patient was recommended a total excision of the lesion for cosmetic improvement and was referred to plastic surgery department. However, she was not able to be followed up.</p>
      <fig id="F1" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Clinical appearance of the skin lesion. A white to grayish, 10 &#xD7; 7 cm sized, irregularly bordered patch with brown to tan colored macules inside the patch was observed.</p>
        </caption>
        <graphic xlink:href="ajd-37-e137-g001"/>
      </fig>
      <fig id="F2" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Histopathologic examination from the center of depigmented patch. A, Nests and cords of nevus cells not containing melanin pigment were seen in the mid-to-deep dermis. B, Dense mononuclear cell (arrow head) infiltrated around the nevus cells (arrow) in superficial dermis and periadnexal structures. Hematoxylin and eosin, original magnification: (A) &#xD7;40; (B) &#xD7;400.</p>
        </caption>
        <graphic xlink:href="ajd-37-e137-g002"/>
      </fig>
      <fig id="F3" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>A, The immunophenotype analysis of the mononuclear infiltrate revealed that the cells were composed predominantly of CD5-positive T cells. B, Few cells were CD20-positive B cells. C and D, CD4:CD8 ratio was approximately 1:6. (A) CD5, &#xD7;200; (B) CD20, &#xD7;200; (C) CD4, &#xD7;200; (D) CD8, &#xD7;200.</p>
        </caption>
        <graphic xlink:href="ajd-37-e137-g003"/>
      </fig>
    </sec>
    <sec sec-type="discussion" id="s3">
      <title>DISCUSSION</title>
      <p>CMN is common and occurs in 0.6&#x2013;1.6 of 5 newborns.<xref rid="R11" ref-type="bibr">11</xref> Few reports about spontaneous regression of CMN are published, and regression of medium-sized CMN is known to be even less common than that of larger variants.<xref rid="R12" ref-type="bibr">12</xref> Most CMN cases with spontaneous regression and halo phenomenon are associated with development of vitiligo at a distant site.<xref rid="R4" ref-type="bibr">4</xref>&#x2013;<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R11" ref-type="bibr">11</xref> Spontaneous regression of CMN without halo formation is a more exceptional case.<xref rid="R13" ref-type="bibr">13</xref></p>
      <p>The exact pathogenesis of halo phenomenon or spontaneous regression of CMN is unknown. In both halo nevus and vitiligo, mononuclear cell infiltration in close contact with ultrastructurally damaged melanocytes<xref rid="R14" ref-type="bibr">14</xref> was seen histopathologically. Eighty percent of the mononuclear infiltrate was found to be T lymphocytes with a relatively high percentage of suppressor/cytotoxic T cells.<xref rid="R15" ref-type="bibr">15</xref> Nevomelanocytes of halo nevus express major histocompatibility complex class I (HLA-A, HLA-B, HLA-C) antigens that allow them to be recognized by cytotoxic T lymphocytes and attack them.<xref rid="R15" ref-type="bibr">15</xref> However, IgM or IgG autoantibodies against melanocytes have been found in the serum of patients with both halo nevi and vitiligo, suggesting that humoral immune reaction accounts for the destruction of melanocytes.<xref rid="R16" ref-type="bibr">16</xref>&#x2013;<xref rid="R18" ref-type="bibr">18</xref> CMN with halo phenomenon we report here belongs to the inflammatory type of halo nevus, which is characterized by the presence of a marked mononuclear inflammatory infiltrate.<xref rid="R18" ref-type="bibr">18</xref> By immunophenotype analysis, we could see that the majority of the infiltrated inflammatory cells were T cells with relatively high proportion of CD8<sup>+</sup> T cells, and this could be an another example of evidence that cytotoxic T-cell immunity plays an important role in the regression and halo phenomenon of CMN. Another interesting finding of our case was that the mononuclear infiltrate was concentrated at the upper dermis and periadnexal areas. This could be explained by the target specificity of nevus cells recognized by T cells, and the expression of the determinants may be greater in the upper dermis and periadnexal areas.<xref rid="R18" ref-type="bibr">18</xref></p>
      <p>There have been several reports about the association of halo nevi and malignant melanoma,<xref rid="R19" ref-type="bibr">19</xref>,<xref rid="R20" ref-type="bibr">20</xref> which support the hypothesis that cytotoxic lymphocytes attack both melanoma cells and nevomelanocytes sharing antigenic determinants. Although such cases are rarely described, in case of CMN that shows pigmentary regression, biopsy must be performed to find out the presence of any malignant change with a careful whole body inspection.<xref rid="R21" ref-type="bibr">21</xref> In our case, there was no malignant change of nevus cells by histopathologic examination or other suspicious lesion by physical examination.</p>
      <p>Here, we report an interesting case that could be an additional evidence for the role of cytotoxic T-cell immunity in regression and halo phenomenon in CMN and that there is a target specificity of nevus cells to be recognized by T cells.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>The authors declare no conflicts of interest.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="R1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krengel</surname><given-names>S</given-names></name><name><surname>Hauschild</surname><given-names>A</given-names></name><name><surname>Schafer</surname><given-names>T</given-names></name></person-group>
<article-title>Melanoma risk in congenital melanocytic naevi: a systematic review</article-title>. <source>Br J Dermatol.</source>
<year>2006</year>;<volume>155</volume>:<fpage>1</fpage>&#x2013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">16792745</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berg</surname><given-names>P</given-names></name><name><surname>Lindelof</surname><given-names>B</given-names></name></person-group>
<article-title>Congenital melanocytic naevi and cutaneous melanoma</article-title>. <source>Melanoma Res.</source>
<year>2003</year>;<volume>13</volume>:<fpage>441</fpage>&#x2013;<lpage>445</lpage>..<pub-id pub-id-type="pmid">14512785</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drakensjo</surname><given-names>IT</given-names></name><name><surname>Hedblad</surname><given-names>MA</given-names></name><name><surname>Wahlgren</surname><given-names>CF</given-names></name></person-group>
<article-title>Rapidly involuting congenital melanocytic naevi in two children</article-title>. <source>Acta Derm Venereol.</source>
<year>2012</year>;<volume>92</volume>:<fpage>605</fpage>&#x2013;<lpage>606</lpage>.<pub-id pub-id-type="pmid">22855272</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silveira</surname><given-names>ML</given-names></name><name><surname>Ferreira</surname><given-names>FR</given-names></name><name><surname>Alvarenga</surname><given-names>ML</given-names></name><etal/></person-group>
<article-title>Association of giant congenital melanocytic nevus, halo nevus and vitiligo in a 75-year-old patient</article-title>. <source>An Bras Dermatol.</source>
<year>2012</year>;<volume>87</volume>:<fpage>288</fpage>&#x2013;<lpage>291</lpage>.<pub-id pub-id-type="pmid">22570035</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nath</surname><given-names>AK</given-names></name><name><surname>Thappa</surname><given-names>DM</given-names></name><name><surname>Rajesh</surname><given-names>NG</given-names></name></person-group>
<article-title>Spontaneous regression of a congenital melanocytic nevus</article-title>. <source>Indian J Dermatol Venereol Leprol.</source>
<year>2011</year>;<volume>77</volume>:<fpage>507</fpage>&#x2013;<lpage>510</lpage>.<pub-id pub-id-type="pmid">21727701</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Goh</surname><given-names>BK</given-names></name></person-group>
<article-title>Vitiligo occurring after halo formation around congenital melanocytic nevi</article-title>. <source>Pediatr Dermatol.</source>
<year>2009</year>;<volume>26</volume>:<fpage>755</fpage>&#x2013;<lpage>756</lpage>.<pub-id pub-id-type="pmid">20199462</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofmann</surname><given-names>UB</given-names></name><name><surname>Brocker</surname><given-names>EB</given-names></name><name><surname>Hamm</surname><given-names>H</given-names></name></person-group>
<article-title>Simultaneous onset of segmental vitiligo and a halo surrounding a congenital melanocytic naevus</article-title>. <source>Acta Derm Venereol.</source>
<year>2009</year>;<volume>89</volume>:<fpage>402</fpage>&#x2013;<lpage>406</lpage>.<pub-id pub-id-type="pmid">19688155</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arpaia</surname><given-names>N</given-names></name><name><surname>Cassano</surname><given-names>N</given-names></name><name><surname>Filotico</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Unusual clinical presentation of regression in a congenital melanocytic nevus</article-title>. <source>Dermatol Surg.</source>
<year>2005</year>;<volume>31</volume>:<fpage>471</fpage>&#x2013;<lpage>473</lpage>.<pub-id pub-id-type="pmid">15871327</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musette</surname><given-names>P</given-names></name><name><surname>Bachelez</surname><given-names>H</given-names></name><name><surname>Flageul</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Immune-mediated destruction of melanocytes in halo nevi is associated with the local expansion of a limited number of T cell clones</article-title>. <source>J Immunol.</source>
<year>1999</year>;<volume>162</volume>:<fpage>1789</fpage>&#x2013;<lpage>1794</lpage>.<pub-id pub-id-type="pmid">9973443</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandt</surname><given-names>O</given-names></name><name><surname>Christophers</surname><given-names>E</given-names></name><name><surname>Folster-Holst</surname><given-names>R</given-names></name></person-group>
<article-title>Halo dermatitis followed by the development of vitiligo associated with Sutton's nevi</article-title>. <source>J Am Acad Dermatol.</source>
<year>2005</year>;<volume>52</volume>:<fpage>S101</fpage>&#x2013;<lpage>S104</lpage>.<pub-id pub-id-type="pmid">15858503</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itin</surname><given-names>PH</given-names></name><name><surname>Lautenschlager</surname><given-names>S</given-names></name></person-group>
<article-title>Acquired leukoderma in congenital pigmented nevus associated with vitiligo-like depigmentation</article-title>. <source>Pediatr Dermatol.</source>
<year>2002</year>;<volume>19</volume>:<fpage>73</fpage>&#x2013;<lpage>75</lpage>.<pub-id pub-id-type="pmid">11860577</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cusack</surname><given-names>C</given-names></name><name><surname>Warde</surname><given-names>D</given-names></name><name><surname>Lynch</surname><given-names>W</given-names></name><etal/></person-group>
<article-title>Dramatic spontaneous regression of a medium-sized congenital melanocytic naevus</article-title>. <source>Clin Exp Dermatol.</source>
<year>2009</year>;<volume>34</volume>:<fpage>e34</fpage>&#x2013;<lpage>e36</lpage>.<pub-id pub-id-type="pmid">19508472</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kageshita</surname><given-names>T</given-names></name><name><surname>Inoue</surname><given-names>Y</given-names></name><name><surname>Ono</surname><given-names>T</given-names></name></person-group>
<article-title>Spontaneous regression of congenital melanocytic nevi without evidence of the halo phenomenon</article-title>. <source>Dermatology</source>. <year>2003</year>;<volume>207</volume>:<fpage>193</fpage>&#x2013;<lpage>195</lpage>.<pub-id pub-id-type="pmid">12920373</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>K</given-names></name></person-group>
<article-title>Ultrastructural studies of halo nevus</article-title>. <source>Cancer</source>. <year>1974</year>;<volume>34</volume>:<fpage>1653</fpage>&#x2013;<lpage>1666</lpage>.<pub-id pub-id-type="pmid">4426029</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berman</surname><given-names>A</given-names></name></person-group>
<article-title>Depigmented haloes associated with the involution of flag warts</article-title>. <source>Br J Dermatol.</source>
<year>1977</year>;<volume>97</volume>:<fpage>263</fpage>&#x2013;<lpage>265</lpage>.<pub-id pub-id-type="pmid">921896</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berman</surname><given-names>B</given-names></name><name><surname>Shaieb</surname><given-names>AM</given-names></name><name><surname>France</surname><given-names>DS</given-names></name><etal/></person-group>
<article-title>Halo giant congenital melanocytic nevus: in vitro immunologic studies</article-title>. <source>J Am Acad Dermatol.</source>
<year>1988</year>;<volume>19</volume>:<fpage>954</fpage>&#x2013;<lpage>960</lpage>.<pub-id pub-id-type="pmid">3057001</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hertz</surname><given-names>KC</given-names></name><name><surname>Gazze</surname><given-names>LA</given-names></name><name><surname>Kirkpatrick</surname><given-names>CH</given-names></name><etal/></person-group>
<article-title>Autoimmune vitiligo: detection of antibodies to melanin-producing cells</article-title>. <source>N Engl J Med.</source>
<year>1977</year>;<volume>297</volume>:<fpage>634</fpage>&#x2013;<lpage>637</lpage>.<pub-id pub-id-type="pmid">331108</pub-id></mixed-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tokura</surname><given-names>Y</given-names></name><name><surname>Yamanaka</surname><given-names>K</given-names></name><name><surname>Wakita</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Halo congenital nevus undergoing spontaneous regression. Involvement of T-cell immunity in involution and presence of circulating anti-nevus cell IgM antibodies</article-title>. <source>Arch Dermatol.</source>
<year>1994</year>;<volume>130</volume>:<fpage>1036</fpage>&#x2013;<lpage>1041</lpage>.<pub-id pub-id-type="pmid">8053701</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Copeman</surname><given-names>PW</given-names></name><name><surname>Lewis</surname><given-names>MG</given-names></name><name><surname>Phillips</surname><given-names>TM</given-names></name><etal/></person-group>
<article-title>Immunological associations of the halo naevus with cutaneous malignant melanoma</article-title>. <source>Br J Dermatol.</source>
<year>1973</year>;<volume>88</volume>:<fpage>127</fpage>&#x2013;<lpage>137</lpage>.<pub-id pub-id-type="pmid">4574770</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whimster</surname><given-names>IW</given-names></name></person-group>
<article-title>Letter: the halo naevus and cutaneous malignant melanoma</article-title>. <source>Br J Dermatol.</source>
<year>1974</year>;<volume>90</volume>:<fpage>111</fpage>&#x2013;<lpage>113</lpage>.<pub-id pub-id-type="pmid">4811833</pub-id></mixed-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langer</surname><given-names>K</given-names></name><name><surname>Konrad</surname><given-names>K</given-names></name></person-group>
<article-title>Congenital melanocytic nevi with halo phenomenon: report of two cases and a review of the literature</article-title>. <source>J Dermatol Surg Oncol.</source>
<year>1990</year>;<volume>16</volume>:<fpage>377</fpage>&#x2013;<lpage>380</lpage>.<pub-id pub-id-type="pmid">2182687</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
